Synthetic pharmacotherapy for lupus nephritis. - Wikidata - wikimedia - TriplyDB

Synthetic pharmacotherapy for lupus nephritis.

Synthetic pharmacotherapy for lupus nephritis.

http://www.wikidata.org/entity/Q39064602

about

Synthetic pharmacotherapy for lupus nephritis.

http://www.wikidata.org/entity/Q39064602

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Synthetic pharmacotherapy for lupus nephritis.

@en

Synthetic pharmacotherapy for lupus nephritis.

@nl

type

label

Synthetic pharmacotherapy for lupus nephritis.

@en

Synthetic pharmacotherapy for lupus nephritis.

@nl

prefLabel

Synthetic pharmacotherapy for lupus nephritis.

@en

Synthetic pharmacotherapy for lupus nephritis.

@nl

P1433

Q39064602-B36BF756-7DAC-4C58-A5E4-6B314A2BEE05

P1476

Q39064602-D7EFF1F5-A341-4700-9DF2-8406A074EFD3

P2093

Q39064602-5A0A431D-80C6-477D-AFF5-4B1942B50AA9

Q39064602-6D7997BD-8604-446F-8F6D-201E290A2E4E

P2860

Q39064602-02B3D29B-164A-40DD-B21A-068C7F7E7715

Q39064602-0419B186-C16C-40A0-9CF1-1A2627519C89

Q39064602-0784681C-D5F0-4083-B38A-86CB5F4669EC

Q39064602-162650D8-DCEC-4BB5-A1CE-FB74CCB1E2E9

Q39064602-1AF47843-355B-4BC2-91CF-118BB86FBFB1

Q39064602-25FBA783-6457-4910-89F6-0EA1F4111525

Q39064602-2806190A-C5C2-4787-B63B-55FF2F58EBBA

Q39064602-28303712-414A-4E5B-807E-86D45DA2753C

Q39064602-296279AB-DC64-43CD-BE3E-55F035D434B3

Q39064602-29E44E90-F51A-4D3F-805C-1F0426B65C85

P304

Q39064602-D4E76CF8-BF21-4BD7-B7A8-0342CFE7E807

P31

Q39064602-34FE9CA8-9A32-4514-A4B2-0F3A521CD07A

P356

Q39064602-C683E3B4-6D3B-45BE-B362-74E79D781156

P407

Q39064602-02A54D8E-7201-42A5-BB9D-0F607F09D7B9

P433

Q39064602-3355736C-0B9B-4441-8C4C-D7C602E914F9

P478

Q39064602-B77CCE0B-C2EC-4E5A-937C-988CA0294BA6

P577

Q39064602-BD4004BE-BF9B-4590-990A-1CF171865F11

P698

Q39064602-40E78CDE-5FF4-4DC9-AF02-B23E116613BD

P921

Q39064602-296E1540-EC53-4DD3-A776-8777D39B6B07

P356

14656566.2016.1276563

P1433

Expert Opinion on Pharmacotherapy

P1476

Synthetic pharmacotherapy for lupus nephritis.

@en

P2093

C Ponticelli

http://www.w3.org/2001/XMLSchema#string

G Moroni

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocorticoid receptor signaling in health and disease

Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects

Molecular analysis of mammalian circadian rhythms

The evaluation and management of hirsutism.

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.

Cyclosporin-induced hypertension: incidence, pathogenesis and management.

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

P304

175-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1276563

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042710

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy